Angiotech Pharmaceuticals, Inc. (USA) (NASDAQ:ANPI)
A specialty pharmaceutical and medical device company that discovers, develops and markets innovative technologies and medical products for local diseases, and for other complications.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
APJ4RealHoldings
(25.97)
Submitted: 8/6/2010 4:48:25 AM :
Start Price:
$0.55
ANPI Score:
-80.52
Biotech industry. Purchased ANPI on Wednesday 8/4 @$0.55/share
on 8/4/10 bought small speculative stakes in tickers:
ANPI @$0.55/share
BRNC @$3.91/share
HLCS @0.49/share
BGP @1.37/share
HTM @0.748/share
VTG @1.36/share a bevo pick
hoping a couple more than double if the rest tank.
Recs
ExploitTopFools
(99.15)
Submitted: 8/1/2010 10:08:46 PM :
Start Price:
$0.57
ANPI Score:
-82.96
next round of speculative outperformers. very risky (except for the few at the end of the list).
tickers: gkk,anpi,tstr,agen,htm,ddss,vtg,erii,swhc,brnc,chk,bgp,bks,hlcs,cog,jec,gy
Recs
RobertJBanach
(< 20)
Submitted: 7/4/2010 9:02:14 PM :
Start Price:
$0.78
ANPI Score:
-95.83
Positive upside outlook.
Recs
franktejon
(< 20)
Submitted: 7/2/2010 8:36:49 AM :
Start Price:
$0.78
ANPI Score:
-95.83
strong buy at .01
Recs
booda7
(< 20)
Submitted: 10/23/2009 5:50:44 PM :
Start Price:
$1.53
ANPI Score:
-109.22
Great management and real product line...
Recs
Brian7992
(< 20)
Submitted: 8/11/2009 2:29:09 PM :
Start Price:
$1.73
ANPI Score:
-122.86
Because it's cheap
Recs
sempire
(31.63)
Submitted: 8/10/2009 11:27:40 AM :
Start Price:
$1.70
ANPI Score:
-121.55
It's hard to find a good company in this sector that is not over bought, and going sideways, or one that is completely a speculative play. There looks to be some potential in ANPI.
Recs
kschmidt65
(< 20)
Submitted: 7/27/2009 1:53:30 PM :
Start Price:
$1.73
ANPI Score:
-125.24
They are in the high margin niche medical device equipment area. Insider buying in the last few months. Reporting earnings August 6th. They have several products. Approved products are: Drug-Eluting coronary stents with Boston Scientific; Vitagel surgical hemostat with Orthovita; CoSeal surgical sealant with Baxter;Medical Device Products, over 5,000 SKUs. In clinical trials Bio-Seal Biopsy Tract Plug; Option Vena Cava Filter; Ani-Infectgive HemoStream Dialysis Catheter; and MultiStem Stem Cell Therapy. Financing has been tough and they have approval to issue more stock within the next two years.
Recs
urlosen
(< 20)
Submitted: 7/21/2009 9:25:12 AM :
Start Price:
$1.82
ANPI Score:
-130.02
This Business as a whole is booming!!! People are in no time soon predicted to stop getting sick, and this Company has recognized this!!!
Recs
TheBigLab
(40.97)
Submitted: 7/21/2009 12:14:14 AM :
Start Price:
$1.77
ANPI Score:
-128.87
In time.
Recs
Georacing96
(< 20)
Submitted: 6/22/2009 12:59:49 PM :
Start Price:
$1.63
ANPI Score:
-137.52
New technology comming onto the market. Growth in their new product.
Recs
BOSTONSTRANGLER
(76.57)
Submitted: 6/17/2009 4:17:33 PM :
Start Price:
$1.81
ANPI Score:
-136.42
VOLUME, FDA APPROVAL, BLACKSTONES INVOLVMENT, VOLUME, VOLUME VOLUME
Recs
foolishtestarino
(< 20)
Submitted: 6/8/2009 10:43:45 AM :
Start Price:
$2.47
ANPI Score:
-136.26
asdf
Recs
fburks
(< 20)
Submitted: 9/3/2008 9:18:13 AM :
Start Price:
$1.62
ANPI Score:
-95.35
First of all I have a very small position in this company. I based this position of my professional use of one of its products: Quills self retaining sutures. This is a great product that will probably grow in its use. I know this company has struggled with debt and reduced stent income, but I would still consider it a buy.
Recs
Fatiggy
(67.92)
Submitted: 8/1/2008 2:11:01 PM :
Start Price:
$2.01
ANPI Score:
-99.62
solid fundamentals
Recs
Toddq34
(< 20)
Submitted: 4/4/2008 1:05:57 PM :
Start Price:
$2.85
ANPI Score:
-93.71
Angiotech Pharmaceuticals, Inc. is a specialty pharmaceutical and medical device company that discovers, develops and markets technologies primarily focused on acute and surgical applications. The Company generates its revenue through the sales of medical products and components, as well as from royalties derived from sales by its partners of products utilizing certain of its own technologies. The Company operates in two segments: Pharmaceutical Technologies and Medical Products. The Pharmaceuticals Technologies segment includes royalty revenue and gross margin generated from out-licensing technology related to the drug-eluting stent and other technologies. As of December 31, 2007, the Company’s principal revenues in this segment come from royalties derived from sales by Boston Scientific Corporation (BSC) of TAXUS coronary stent systems incorporating the drug paclitaxel. The Medical Products segment includes revenues and gross margins of single use, specialty medical devices.
Recs
JCSmiley
(90.39)
Submitted: 3/10/2008 2:00:03 PM :
Start Price:
$3.03
ANPI Score:
-95.46
Anyone willing to hang on to this one for 5+ years will be rewarded! :)
Nice niche market.
Recs
jroack
(83.89)
Submitted: 1/16/2008 11:16:11 AM :
Start Price:
$3.30
ANPI Score:
-95.76
Promising product line on the expanding edge of this trend. Beaten to a pulp at this point. Time to buy.
Recs
hutch610
(< 20)
Submitted: 1/6/2008 8:28:53 PM :
Start Price:
$3.56
ANPI Score:
-92.81
Been beaten down badly and set for a rebound soon.
Recs
morningstarboy
(42.49)
Submitted: 12/5/2007 12:47:41 PM :
Start Price:
$3.86
ANPI Score:
-89.07
As of close of business on 12/04/2007, this was a 5-star Morningstar stock that was trading below half of it's Morningstar fair value.
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 35 : 1 2 Next »